Expansion
from
tx.fhir.org
based
on
codesystem
Vaccine
Administered
Code
Set
(CVX)
version20231214
version
20250715
Code
System
|
System
Code
|
Display
|
Display
(English)
|
01
http://hl7.org/fhir/sid/cvx
|
01
|
DTP
|
diphtheria,
tetanus
toxoids
and
pertussis
vaccine
|
02
http://hl7.org/fhir/sid/cvx
|
02
|
OPV
OPV,
trivalent
|
trivalent
poliovirus
vaccine,
live,
oral
|
03
http://hl7.org/fhir/sid/cvx
|
03
|
MMR
|
measles,
mumps
and
rubella
virus
vaccine
|
04
http://hl7.org/fhir/sid/cvx
|
04
|
M/R
|
measles
and
rubella
virus
vaccine
|
05
http://hl7.org/fhir/sid/cvx
|
05
|
measles
|
measles
virus
vaccine
|
06
http://hl7.org/fhir/sid/cvx
|
06
|
rubella
|
rubella
virus
vaccine
|
07
http://hl7.org/fhir/sid/cvx
|
07
|
mumps
|
mumps
virus
vaccine
|
08
http://hl7.org/fhir/sid/cvx
|
08
|
Hep
B,
adolescent
or
pediatric
|
hepatitis
B
vaccine,
pediatric
or
pediatric/adolescent
dosage
|
09
http://hl7.org/fhir/sid/cvx
|
09
|
Td
(adult),
2
Lf
tetanus
toxoid,
preservative
free,
adsorbed
|
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use
(2
Lf
of
tetanus
toxoid
and
2
Lf
of
diphtheria
toxoid)
|
10
http://hl7.org/fhir/sid/cvx
|
10
|
IPV
|
poliovirus
vaccine,
inactivated
|
11
http://hl7.org/fhir/sid/cvx
|
11
|
pertussis
|
pertussis
vaccine
|
12
http://hl7.org/fhir/sid/cvx
|
12
|
diphtheria
antitoxin
|
diphtheria
antitoxin
|
13
http://hl7.org/fhir/sid/cvx
|
13
|
TIG
|
tetanus
immune
globulin
|
14
http://hl7.org/fhir/sid/cvx
|
14
|
IG,
unspecified
formulation
|
immune
globulin,
unspecified
formulation
|
15
http://hl7.org/fhir/sid/cvx
|
15
|
influenza,
split
(incl.
purified
surface
antigen)
|
influenza
virus
vaccine,
split
virus
(incl.
purified
surface
antigen)-retired
CODE
|
16
http://hl7.org/fhir/sid/cvx
|
16
|
influenza,
whole
|
influenza
virus
vaccine,
whole
virus
|
17
http://hl7.org/fhir/sid/cvx
|
17
|
Hib,
unspecified
formulation
|
Haemophilus
influenzae
type
b
vaccine,
conjugate
unspecified
formulation
|
18
http://hl7.org/fhir/sid/cvx
|
18
|
rabies,
intramuscular
injection
|
rabies
vaccine,
for
intramuscular
injection
RETIRED
CODE
|
19
http://hl7.org/fhir/sid/cvx
|
19
|
BCG
|
Bacillus
Calmette-Guerin
vaccine
|
20
http://hl7.org/fhir/sid/cvx
|
20
|
DTaP
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine
|
21
http://hl7.org/fhir/sid/cvx
|
21
|
varicella
|
varicella
virus
vaccine
|
22
http://hl7.org/fhir/sid/cvx
|
22
|
DTP-Hib
|
DTP-Haemophilus
influenzae
type
b
conjugate
vaccine
|
23
http://hl7.org/fhir/sid/cvx
|
23
|
plague
|
plague
vaccine
|
24
http://hl7.org/fhir/sid/cvx
|
24
|
anthrax
Anthrax,
pre-exposure
prophylaxis,
post-exposure
prophylaxis
|
anthrax
vaccine
Anthrax
vaccine,
adsorbed,
pre-exposure
and
post-exposure
prophylaxis
|
25
http://hl7.org/fhir/sid/cvx
|
25
|
typhoid,
oral
|
typhoid
vaccine,
live,
oral
|
26
http://hl7.org/fhir/sid/cvx
|
26
|
cholera,
unspecified
formulation
|
cholera
vaccine,
unspecified
formulation
|
27
http://hl7.org/fhir/sid/cvx
|
27
|
botulinum
antitoxin
|
botulinum
antitoxin
|
28
http://hl7.org/fhir/sid/cvx
|
28
|
DT
(pediatric)
|
diphtheria
and
tetanus
toxoids,
adsorbed
for
pediatric
use
|
29
http://hl7.org/fhir/sid/cvx
|
29
|
CMVIG
|
cytomegalovirus
immune
globulin,
intravenous
|
30
http://hl7.org/fhir/sid/cvx
|
30
|
HBIG
|
hepatitis
B
immune
globulin
|
31
http://hl7.org/fhir/sid/cvx
|
31
|
Hep
A,
pediatric,
unspecified
formulation
|
hepatitis
A
vaccine,
pediatric
dosage,
unspecified
formulation
|
32
http://hl7.org/fhir/sid/cvx
|
32
|
meningococcal
MPSV4
|
meningococcal
polysaccharide
vaccine
(MPSV4)
|
33
http://hl7.org/fhir/sid/cvx
|
33
|
pneumococcal
polysaccharide
PPV23
|
pneumococcal
polysaccharide
vaccine,
23
valent
|
34
http://hl7.org/fhir/sid/cvx
|
34
|
RIG
|
rabies
immune
globulin
|
35
http://hl7.org/fhir/sid/cvx
|
35
|
tetanus
toxoid,
adsorbed
|
tetanus
toxoid,
adsorbed
|
36
http://hl7.org/fhir/sid/cvx
|
36
|
VZIG
|
varicella
zoster
immune
globulin
|
37
http://hl7.org/fhir/sid/cvx
|
37
|
yellow
fever
live
|
yellow
fever
vaccine
live
|
38
http://hl7.org/fhir/sid/cvx
|
38
|
rubella/mumps
|
rubella
and
mumps
virus
vaccine
|
39
http://hl7.org/fhir/sid/cvx
|
39
|
Japanese
encephalitis
SC
|
Japanese
Encephalitis
Vaccine
SC
|
40
http://hl7.org/fhir/sid/cvx
|
40
|
rabies,
intradermal
injection
|
rabies
vaccine,
for
intradermal
injection
|
41
http://hl7.org/fhir/sid/cvx
|
41
|
typhoid,
parenteral
|
typhoid
vaccine,
parenteral,
other
than
acetone-killed,
dried
|
42
http://hl7.org/fhir/sid/cvx
|
42
|
Hep
B,
adolescent/high
risk
infant
|
hepatitis
B
vaccine,
adolescent/high
risk
infant
dosage
|
43
http://hl7.org/fhir/sid/cvx
|
43
|
Hep
B,
adult
|
hepatitis
B
vaccine,
adult
dosage
|
44
http://hl7.org/fhir/sid/cvx
|
44
|
Hep
B,
high-dosage,
dialysis
or
IC
|
hepatitis
Hepatitis
B
vaccine,
vaccine
(Hep
B),
high-dosage,
dialysis
or
immunocompromised
patient
dosage
|
45
http://hl7.org/fhir/sid/cvx
|
45
|
Hep
B,
unspecified
formulation
|
hepatitis
B
vaccine,
unspecified
formulation
|
46
http://hl7.org/fhir/sid/cvx
|
46
|
Hib
(PRP-D)
|
Haemophilus
influenzae
type
b
vaccine,
PRP-D
conjugate
|
47
http://hl7.org/fhir/sid/cvx
|
47
|
Hib
(HbOC)
|
Haemophilus
influenzae
type
b
vaccine,
HbOC
conjugate
|
48
http://hl7.org/fhir/sid/cvx
|
48
|
Hib
(PRP-T)
|
Haemophilus
influenzae
type
b
vaccine,
PRP-T
conjugate
|
49
http://hl7.org/fhir/sid/cvx
|
49
|
Hib
(PRP-OMP)
|
Haemophilus
influenzae
type
b
vaccine,
PRP-OMP
conjugate
|
50
http://hl7.org/fhir/sid/cvx
|
50
|
DTaP-Hib
|
DTaP-Haemophilus
influenzae
type
b
conjugate
vaccine
|
51
http://hl7.org/fhir/sid/cvx
|
51
|
Hib-Hep
B
|
Haemophilus
influenzae
type
b
conjugate
and
Hepatitis
B
vaccine
|
52
http://hl7.org/fhir/sid/cvx
|
52
|
Hep
A,
adult
|
hepatitis
A
vaccine,
adult
dosage
|
53
http://hl7.org/fhir/sid/cvx
|
53
|
typhoid,
parenteral,
AKD
(U.S.
military)
|
typhoid
vaccine,
parenteral,
acetone-killed,
dried
(U.S.
military)
|
54
http://hl7.org/fhir/sid/cvx
|
54
|
adenovirus,
type
4
|
adenovirus
vaccine,
type
4,
live,
oral
|
55
http://hl7.org/fhir/sid/cvx
|
55
|
adenovirus,
type
7
|
adenovirus
vaccine,
type
7,
live,
oral
|
56
http://hl7.org/fhir/sid/cvx
|
56
|
dengue
fever
tetravalent
|
dengue
fever
vaccine,
tetravalent
|
57
http://hl7.org/fhir/sid/cvx
|
57
|
hantavirus
|
hantavirus
vaccine
|
58
http://hl7.org/fhir/sid/cvx
|
58
|
Hep
C
|
hepatitis
C
vaccine
|
59
http://hl7.org/fhir/sid/cvx
|
59
|
Hep
E
|
hepatitis
E
vaccine
|
60
http://hl7.org/fhir/sid/cvx
|
60
|
herpes
simplex
2
|
herpes
simplex
virus,
type
2
vaccine
|
61
http://hl7.org/fhir/sid/cvx
|
61
|
HIV
|
human
immunodeficiency
virus
vaccine
|
62
http://hl7.org/fhir/sid/cvx
|
62
|
HPV,
quadrivalent
|
human
papilloma
virus
vaccine,
quadrivalent
|
63
http://hl7.org/fhir/sid/cvx
|
63
|
Junin
virus
|
Junin
virus
vaccine
|
64
http://hl7.org/fhir/sid/cvx
|
64
|
leishmaniasis
|
leishmaniasis
vaccine
|
65
http://hl7.org/fhir/sid/cvx
|
65
|
leprosy
|
leprosy
vaccine
|
66
http://hl7.org/fhir/sid/cvx
|
66
|
Lyme
disease
|
Lyme
disease
vaccine
|
67
http://hl7.org/fhir/sid/cvx
|
67
|
malaria
|
malaria
vaccine
|
68
http://hl7.org/fhir/sid/cvx
|
68
|
melanoma
|
melanoma
vaccine
|
69
http://hl7.org/fhir/sid/cvx
|
69
|
parainfluenza-3
|
parainfluenza-3
virus
vaccine
|
70
http://hl7.org/fhir/sid/cvx
|
70
|
Q
fever
|
Q
fever
vaccine
|
71
http://hl7.org/fhir/sid/cvx
|
71
|
RSV-IGIV
|
respiratory
syncytial
virus
immune
globulin,
intravenous
|
72
http://hl7.org/fhir/sid/cvx
|
72
|
rheumatic
fever
|
rheumatic
fever
vaccine
|
73
http://hl7.org/fhir/sid/cvx
|
73
|
Rift
Valley
fever
|
Rift
Valley
fever
vaccine
|
74
http://hl7.org/fhir/sid/cvx
|
74
|
rotavirus,
tetravalent
|
rotavirus,
live,
tetravalent
vaccine
|
75
http://hl7.org/fhir/sid/cvx
|
75
|
vaccinia
(smallpox)
Vaccinia
(smallpox,
mpox),
live
|
vaccinia
(smallpox)
vaccine
Vaccinia
(smallpox,
mpox)
vaccine,
live
|
76
http://hl7.org/fhir/sid/cvx
|
76
|
Staphylococcus
bacterio
lysate
|
Staphylococcus
bacteriophage
lysate
|
77
http://hl7.org/fhir/sid/cvx
|
77
|
Tick-borne
encephalitis
vaccine
(non-US)
|
Tick-borne
encephalitis
vaccine
(non-US)
|
78
http://hl7.org/fhir/sid/cvx
|
78
|
tularemia
vaccine
|
tularemia
vaccine
|
79
http://hl7.org/fhir/sid/cvx
|
79
|
vaccinia
immune
globulin
|
vaccinia
immune
globulin
|
80
http://hl7.org/fhir/sid/cvx
|
80
|
VEE,
live
|
Venezuelan
equine
encephalitis,
live,
attenuated
|
81
http://hl7.org/fhir/sid/cvx
|
81
|
VEE,
inactivated
|
Venezuelan
equine
encephalitis,
inactivated
|
82
http://hl7.org/fhir/sid/cvx
|
82
|
adenovirus,
unspecified
formulation
|
adenovirus
vaccine,
unspecified
formulation
|
83
http://hl7.org/fhir/sid/cvx
|
83
|
Hep
A,
ped/adol,
2
dose
|
hepatitis
A
vaccine,
pediatric/adolescent
dosage,
2
dose
schedule
|
84
http://hl7.org/fhir/sid/cvx
|
84
|
Hep
A,
ped/adol,
3
dose
|
hepatitis
A
vaccine,
pediatric/adolescent
dosage,
3
dose
schedule
|
85
http://hl7.org/fhir/sid/cvx
|
85
|
Hep
A,
unspecified
formulation
|
hepatitis
A
vaccine,
unspecified
formulation
|
86
http://hl7.org/fhir/sid/cvx
|
86
|
IG
|
immune
globulin,
intramuscular
|
87
http://hl7.org/fhir/sid/cvx
|
87
|
IGIV
|
immune
globulin,
intravenous
|
88
http://hl7.org/fhir/sid/cvx
|
88
|
influenza,
unspecified
formulation
|
influenza
virus
vaccine,
unspecified
formulation
|
89
http://hl7.org/fhir/sid/cvx
|
89
|
polio,
unspecified
formulation
|
poliovirus
vaccine,
unspecified
formulation
|
90
http://hl7.org/fhir/sid/cvx
|
90
|
rabies,
unspecified
formulation
|
rabies
vaccine,
unspecified
formulation
|
91
http://hl7.org/fhir/sid/cvx
|
91
|
typhoid,
unspecified
formulation
|
typhoid
vaccine,
unspecified
formulation
|
92
http://hl7.org/fhir/sid/cvx
|
92
|
VEE,
unspecified
formulation
|
Venezuelan
equine
encephalitis
vaccine,
unspecified
formulation
|
93
http://hl7.org/fhir/sid/cvx
|
93
|
RSV-MAb
|
respiratory
syncytial
virus
monoclonal
antibody
(palivizumab),
intramuscular
|
94
http://hl7.org/fhir/sid/cvx
|
94
|
MMRV
|
measles,
mumps,
rubella,
and
varicella
virus
vaccine
|
95
http://hl7.org/fhir/sid/cvx
|
95
|
TST-OT
tine
test
|
tuberculin
skin
test;
old
tuberculin,
multipuncture
device
|
96
http://hl7.org/fhir/sid/cvx
|
96
|
TST-PPD
intradermal
|
tuberculin
skin
test;
purified
protein
derivative
solution,
intradermal
|
97
http://hl7.org/fhir/sid/cvx
|
97
|
TST-PPD
tine
test
|
tuberculin
skin
test;
purified
protein
derivative,
multipuncture
device
|
98
http://hl7.org/fhir/sid/cvx
|
98
|
TST,
unspecified
formulation
|
tuberculin
skin
test;
unspecified
formulation
|
99
http://hl7.org/fhir/sid/cvx
|
99
|
RESERVED
-
do
not
use
|
RESERVED
-
do
not
use
|
100
http://hl7.org/fhir/sid/cvx
|
100
|
pneumococcal
conjugate
PCV
7
|
pneumococcal
conjugate
vaccine,
7
valent
|
101
http://hl7.org/fhir/sid/cvx
|
101
|
typhoid,
ViCPs
|
typhoid
Vi
capsular
polysaccharide
vaccine
|
102
http://hl7.org/fhir/sid/cvx
|
102
|
DTP-Hib-Hep
B
|
DTP-
Haemophilus
influenzae
type
b
conjugate
and
hepatitis
b
vaccine
|
103
http://hl7.org/fhir/sid/cvx
|
103
|
meningococcal
C
conjugate
|
meningococcal
C
conjugate
vaccine
|
104
http://hl7.org/fhir/sid/cvx
|
104
|
Hep
A-Hep
B
|
hepatitis
A
and
hepatitis
B
vaccine
|
105
http://hl7.org/fhir/sid/cvx
|
105
|
vaccinia
(smallpox)
diluted
|
vaccinia
(smallpox)
vaccine,
diluted
|
106
http://hl7.org/fhir/sid/cvx
|
106
|
DTaP,
5
pertussis
antigens
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
5
pertussis
antigens
|
107
http://hl7.org/fhir/sid/cvx
|
107
|
DTaP,
unspecified
formulation
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
unspecified
formulation
|
108
http://hl7.org/fhir/sid/cvx
|
108
|
meningococcal
ACWY,
unspecified
formulation
|
meningococcal
ACWY
vaccine,
unspecified
formulation
|
109
http://hl7.org/fhir/sid/cvx
|
109
|
pneumococcal,
unspecified
formulation
|
pneumococcal
vaccine,
unspecified
formulation
|
110
http://hl7.org/fhir/sid/cvx
|
110
|
DTaP-Hep
B-IPV
|
DTaP-hepatitis
B
and
poliovirus
vaccine
|
111
http://hl7.org/fhir/sid/cvx
|
111
|
influenza,
Influenza,
live,
intranasal
trivalent,
intranasal,
PF
|
influenza
virus
vaccine,
Influenza,
live,
attenuated,
for
intranasal
use
trivalent,
intranasal,
preservative
free
|
112
http://hl7.org/fhir/sid/cvx
|
112
|
tetanus
toxoid,
unspecified
formulation
|
tetanus
toxoid,
unspecified
formulation
|
113
http://hl7.org/fhir/sid/cvx
|
113
|
Td
(adult),
5
Lf
tetanus
toxoid,
preservative
free,
adsorbed
|
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use
(5
Lf
of
tetanus
toxoid
and
2
Lf
of
diphtheria
toxoid)
|
114
http://hl7.org/fhir/sid/cvx
|
114
|
meningococcal
MCV4P
|
meningococcal
polysaccharide
(groups
A,
C,
Y
and
W-135)
diphtheria
toxoid
conjugate
vaccine
(MCV4P)
|
115
http://hl7.org/fhir/sid/cvx
|
115
|
Tdap
|
tetanus
toxoid,
reduced
diphtheria
toxoid,
and
acellular
pertussis
vaccine,
adsorbed
|
116
http://hl7.org/fhir/sid/cvx
|
116
|
rotavirus,
pentavalent
|
rotavirus,
live,
pentavalent
vaccine
|
117
http://hl7.org/fhir/sid/cvx
|
117
|
VZIG
(IND)
|
varicella
zoster
immune
globulin
(Investigational
New
Drug)
|
118
http://hl7.org/fhir/sid/cvx
|
118
|
HPV,
bivalent
|
human
papilloma
virus
vaccine,
bivalent
|
119
http://hl7.org/fhir/sid/cvx
|
119
|
rotavirus,
monovalent
|
rotavirus,
live,
monovalent
vaccine
|
120
http://hl7.org/fhir/sid/cvx
|
120
|
DTaP-Hib-IPV
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
Haemophilus
influenzae
type
b
conjugate,
and
poliovirus
vaccine,
inactivated
(DTaP-Hib-IPV)
|
121
http://hl7.org/fhir/sid/cvx
|
121
|
zoster
live
|
zoster
vaccine,
live
|
122
http://hl7.org/fhir/sid/cvx
|
122
|
rotavirus,
unspecified
formulation
|
rotavirus
vaccine,
unspecified
formulation
|
123
http://hl7.org/fhir/sid/cvx
|
123
|
influenza,
H5N1-1203
|
influenza
virus
vaccine,
H5N1,
A/Vietnam/1203/2004
(national
stockpile)
|
125
http://hl7.org/fhir/sid/cvx
|
125
|
Novel
Influenza-H1N1-09,
nasal
|
Novel
Influenza-H1N1-09,
live
virus
for
nasal
administration
|
126
http://hl7.org/fhir/sid/cvx
|
126
|
Novel
influenza-H1N1-09,
preservative-free
|
Novel
influenza-H1N1-09,
preservative-free,
injectable
|
127
http://hl7.org/fhir/sid/cvx
|
127
|
Novel
influenza-H1N1-09
|
Novel
influenza-H1N1-09,
injectable
|
128
http://hl7.org/fhir/sid/cvx
|
128
|
Novel
Influenza-H1N1-09,
all
formulations
|
Novel
influenza-H1N1-09,
all
formulations
|
129
http://hl7.org/fhir/sid/cvx
|
129
|
Japanese
Encephalitis,
unspecified
formulation
|
Japanese
Encephalitis
vaccine,
unspecified
formulation
|
130
http://hl7.org/fhir/sid/cvx
|
130
|
DTaP-IPV
|
Diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
and
poliovirus
vaccine,
inactivated
|
131
http://hl7.org/fhir/sid/cvx
|
131
|
typhus,
historical
|
Historical
record
of
a
typhus
vaccination
|
132
http://hl7.org/fhir/sid/cvx
|
132
|
DTaP-IPV-HIB-HEP
B,
historical
|
Historical
diphtheria
and
tetanus
toxoids
and
acellular
pertussis,
poliovirus,
Haemophilus
b
conjugate
and
hepatitis
B
(recombinant)
vaccine.
|
133
http://hl7.org/fhir/sid/cvx
|
133
|
Pneumococcal
conjugate
PCV
13
|
pneumococcal
conjugate
vaccine,
13
valent
|
134
http://hl7.org/fhir/sid/cvx
|
134
|
Japanese
Encephalitis
IM
|
Japanese
Encephalitis
vaccine
for
intramuscular
administration
|
135
http://hl7.org/fhir/sid/cvx
|
135
|
Influenza,
high
dose
seasonal
high-dose,
trivalent,
PF
|
influenza,
high
dose
seasonal,
preservative-free
Influenza,
high-dose,
split
virus,
trivalent,
injectable,
preservative
free
|
136
http://hl7.org/fhir/sid/cvx
|
136
|
Meningococcal
MCV4O
|
meningococcal
oligosaccharide
(groups
A,
C,
Y
and
W-135)
diphtheria
toxoid
conjugate
vaccine
(MCV4O)
|
137
http://hl7.org/fhir/sid/cvx
|
137
|
HPV,
unspecified
formulation
|
HPV,
unspecified
formulation
|
138
http://hl7.org/fhir/sid/cvx
|
138
|
Td
(adult)
|
tetanus
and
diphtheria
toxoids,
not
adsorbed,
for
adult
use
|
139
http://hl7.org/fhir/sid/cvx
|
139
|
Td(adult)
unspecified
formulation
|
Td(adult)
unspecified
formulation
|
140
http://hl7.org/fhir/sid/cvx
|
140
|
Influenza,
seasonal,
injectable,
preservative
free
split
virus,
trivalent,
PF
|
Influenza,
seasonal,
split
virus,
trivalent,
injectable,
preservative
free
|
141
http://hl7.org/fhir/sid/cvx
|
141
|
Influenza,
seasonal,
injectable
split
virus,
trivalent,
preservative
|
Influenza,
seasonal,
injectable
split
virus,
trivalent,
injectable,
contains
preservative
|
142
http://hl7.org/fhir/sid/cvx
|
142
|
tetanus
toxoid,
not
adsorbed
|
tetanus
toxoid,
not
adsorbed
|
143
http://hl7.org/fhir/sid/cvx
|
143
|
Adenovirus
types
4
and
7
|
Adenovirus,
type
4
and
type
7,
live,
oral
|
144
http://hl7.org/fhir/sid/cvx
|
144
|
influenza,
seasonal,
intradermal,
preservative
free
|
seasonal
influenza,
intradermal,
preservative
free
|
145
http://hl7.org/fhir/sid/cvx
|
145
|
RSV-MAb
(new)
|
respiratory
syncytial
virus
monoclonal
antibody
(motavizumab),
intramuscular
|
146
http://hl7.org/fhir/sid/cvx
|
146
|
DTaP,IPV,Hib,HepB
|
Diphtheria
and
Tetanus
Toxoids
and
Acellular
Pertussis
Adsorbed,
Inactivated
Poliovirus,
Haemophilus
b
Conjugate
(Meningococcal
Protein
Conjugate),
and
Hepatitis
B
(Recombinant)
Vaccine.
|
147
http://hl7.org/fhir/sid/cvx
|
147
|
meningococcal
MCV4,
unspecified
formulation
|
Meningococcal,
MCV4,
unspecified
conjugate
formulation(groups
A,
C,
Y
and
W-135)
|
148
http://hl7.org/fhir/sid/cvx
|
148
|
Meningococcal
C/Y-HIB
PRP
|
Meningococcal
Groups
C
and
Y
and
Haemophilus
b
Tetanus
Toxoid
Conjugate
Vaccine
|
149
http://hl7.org/fhir/sid/cvx
|
149
|
influenza,
Influenza,
live,
intranasal,
quadrivalent
quadrivalent,
intranasal
|
influenza,
Influenza,
live,
intranasal,
quadrivalent
quadrivalent,
intranasal
|
150
http://hl7.org/fhir/sid/cvx
|
150
|
influenza,
injectable,
Influenza,
split
virus,
quadrivalent,
preservative
free
PF
|
Influenza,
injectable,
split
virus,
quadrivalent,
injectable,
preservative
free
|
151
http://hl7.org/fhir/sid/cvx
|
151
|
influenza
nasal,
unspecified
formulation
|
influenza
nasal,
unspecified
formulation
|
152
http://hl7.org/fhir/sid/cvx
|
152
|
Pneumococcal
Conjugate,
unspecified
formulation
|
Pneumococcal
Conjugate,
unspecified
formulation
|
153
http://hl7.org/fhir/sid/cvx
|
153
|
Influenza,
injectable,
MDCK,
preservative
free
trivalent,
PF
|
Influenza,
injectable,
Madin
Darby
Canine
Kidney,
subunit,
trivalent,
injectable,
preservative
free
|
154
http://hl7.org/fhir/sid/cvx
|
154
|
Hep
A,
IG
|
Hepatitis
A
immune
globulin
|
155
http://hl7.org/fhir/sid/cvx
|
155
|
influenza,
Influenza,
recombinant,
injectable,
preservative
free
trivalent,
PF
|
Seasonal,
trivalent,
Influenza,
recombinant,
injectable
influenza
vaccine,
trivalent,
injectable,
preservative
free
|
156
http://hl7.org/fhir/sid/cvx
|
156
|
Rho(D)-IG
|
Rho(D)
Immune
globulin-
IV
or
IM
|
157
http://hl7.org/fhir/sid/cvx
|
157
|
Rho(D)
-IG
IM
|
Rho(D)
Immune
globulin
-
IM
|
158
http://hl7.org/fhir/sid/cvx
|
158
|
influenza,
injectable,
quadrivalent
Influenza,
split
virus,
quadrivalent,
preservative
|
influenza,
injectable,
Influenza,
split
virus,
quadrivalent,
injectable,
contains
preservative
|
159
http://hl7.org/fhir/sid/cvx
|
159
|
Rho(D)
-
Unspecified
formulation
|
Rho(D)
Unspecified
formulation
|
160
http://hl7.org/fhir/sid/cvx
|
160
|
Influenza
A
monovalent
(H5N1),
ADJUVANTED-2013
|
Influenza
A
monovalent
(H5N1),
adjuvanted,
National
stockpile
2013
|
161
http://hl7.org/fhir/sid/cvx
|
161
|
Influenza,
injectable,quadrivalent,
preservative
free,
pediatric
|
Influenza,
injectable,quadrivalent,
preservative
free,
pediatric
|
162
http://hl7.org/fhir/sid/cvx
|
162
|
meningococcal
B,
recombinant
|
meningococcal
B
vaccine,
fully
recombinant
|
163
http://hl7.org/fhir/sid/cvx
|
163
|
meningococcal
B,
OMV
|
meningococcal
B
vaccine,
recombinant,
OMV,
adjuvanted
|
164
http://hl7.org/fhir/sid/cvx
|
164
|
meningococcal
B,
unspecified
|
meningococcal
B,
unspecified
formulation
|
165
http://hl7.org/fhir/sid/cvx
|
165
|
HPV9
|
Human
Papillomavirus
9-valent
vaccine
|
166
http://hl7.org/fhir/sid/cvx
|
166
|
influenza,
intradermal,
quadrivalent,
preservative
free
|
influenza,
intradermal,
quadrivalent,
preservative
free,
injectable
|
167
http://hl7.org/fhir/sid/cvx
|
167
|
meningococcal,
unknown
serogroups
|
meningococcal
vaccine
of
unknown
formulation
and
unknown
serogroups
|
168
http://hl7.org/fhir/sid/cvx
|
168
|
influenza,
Influenza,
adjuvanted,
trivalent,
adjuvanted
PF
|
Seasonal
trivalent
influenza
vaccine,
Influenza,
adjuvanted,
inactivated,
trivalent,
injectable,
preservative
free
|
169
http://hl7.org/fhir/sid/cvx
|
169
|
Hep
A,
live
attenuated
|
Hep
A,
live
attenuated-IM
|
170
http://hl7.org/fhir/sid/cvx
|
170
|
DTAP/IPV/HIB
-
non-US
|
non-US
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
Haemophilus
influenzae
type
b
conjugate,
and
poliovirus
vaccine,
inactivated
(DTaP-Hib-IPV)
|
171
http://hl7.org/fhir/sid/cvx
|
171
|
Influenza,
injectable,
MDCK,
preservative
free,
quadrivalent
quadrivalent,
PF
|
Influenza,
injectable,
Madin
Darby
Canine
Kidney,
subunit,
quadrivalent,
injectable,
preservative
free,
quadrivalent
free
|
172
http://hl7.org/fhir/sid/cvx
|
172
|
cholera,
WC-rBS
|
cholera,
WC-rBS
|
173
http://hl7.org/fhir/sid/cvx
|
173
|
cholera,
BivWC
|
cholera,
BivWC
|
174
http://hl7.org/fhir/sid/cvx
|
174
|
cholera,
live
attenuated
|
cholera,
live
attenuated
|
175
http://hl7.org/fhir/sid/cvx
|
175
|
Rabies
-
IM
Diploid
cell
culture
|
Human
Rabies
vaccine
from
human
diploid
cell
culture
|
176
http://hl7.org/fhir/sid/cvx
|
176
|
Rabies
-
IM
fibroblast
culture
|
Human
rabies
vaccine
from
Chicken
fibroblast
culture
|
177
http://hl7.org/fhir/sid/cvx
|
177
|
PCV10
|
pneumococcal
conjugate
vaccine,
10
valent
|
178
http://hl7.org/fhir/sid/cvx
|
178
|
OPV
bivalent
|
Non-US
bivalent
oral
polio
vaccine
(types
1
and
3)
|
179
http://hl7.org/fhir/sid/cvx
|
179
|
OPV
,monovalent,
unspecified
|
Non-US
monovalent
oral
polio
vaccine,
unspecified
formulation
|
180
http://hl7.org/fhir/sid/cvx
|
180
|
tetanus
immune
globulin
|
tetanus
immune
globulin
|
181
http://hl7.org/fhir/sid/cvx
|
181
|
anthrax
immune
globulin
|
anthrax
immune
globulin
|
182
http://hl7.org/fhir/sid/cvx
|
182
|
OPV,
Unspecified
|
Oral
Polio
Vaccine,
Unspecified
formulation
|
183
http://hl7.org/fhir/sid/cvx
|
183
|
Yellow
fever
vaccine
live
-
alt
|
Yellow
fever
vaccine
live
-
alternative
formulation
for
vaccine
shortage
|
184
http://hl7.org/fhir/sid/cvx
|
184
|
Yellow
fever,
unspecified
formulation
|
Yellow
fever
vaccine,
unspecified
formulation
|
185
http://hl7.org/fhir/sid/cvx
|
185
|
influenza,
Influenza,
recombinant,
quadrivalent,injectable,
preservative
free
quadrivalent,
PF
|
Seasonal,
quadrivalent,
Influenza,
recombinant,
injectable
influenza
vaccine,
quadrivalent,
injectable,
preservative
free
|
186
http://hl7.org/fhir/sid/cvx
|
186
|
Influenza,
injectable,
MDCK,
quadrivalent,
preservative
|
Influenza,
injectable,
Madin
Darby
Canine
Kidney,
quadrivalent
with
subunit,
quadrivalent,
injectable,
contains
preservative
|
187
http://hl7.org/fhir/sid/cvx
|
187
|
zoster
recombinant
|
zoster
vaccine
recombinant
|
188
http://hl7.org/fhir/sid/cvx
|
188
|
zoster,
unspecified
formulation
|
zoster
vaccine,
unspecified
formulation
|
189
http://hl7.org/fhir/sid/cvx
|
189
|
HepB-CpG
|
Hepatitis
B
vaccine
(recombinant),
CpG
adjuvanted
|
190
http://hl7.org/fhir/sid/cvx
|
190
|
Typhoid
conjugate
vaccine
(TCV)
|
Typhoid
conjugate
vaccine
(non-US)
|
191
http://hl7.org/fhir/sid/cvx
|
191
|
meningococcal
A
polysaccharide
(non-US)
|
meningococcal
A
polysaccharide
vaccine
(non-US)
|
192
http://hl7.org/fhir/sid/cvx
|
192
|
meningococcal
AC
polysaccharide
(non-US)
|
meningococcal
AC
polysaccharide
vaccine
(non-US)
|
193
http://hl7.org/fhir/sid/cvx
|
193
|
Hep
A-Hep
B,
pediatric/adolescent
|
hepatitis
A
and
hepatitis
B
vaccine,
pediatric/adolescent
(non-US)
|
194
http://hl7.org/fhir/sid/cvx
|
194
|
Influenza,
Southern
Hemisphere
|
influenza,
Southern
Hemisphere,
unspecified
formulation
|
195
http://hl7.org/fhir/sid/cvx
|
195
|
DT,
IPV
adsorbed
|
Diphtheria,
Tetanus,
Poliomyelitis
adsorbed
|
196
http://hl7.org/fhir/sid/cvx
|
196
|
Td,
adsorbed,
preservative
free,
adult
use,
Lf
unspecified
|
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use,
Lf
unspecified
|
197
http://hl7.org/fhir/sid/cvx
|
197
|
influenza,
Influenza,
high-dose,
quadrivalent
quadrivalent,
PF
|
influenza,
high-dose
seasonal,
Influenza,
high-dose,
split
virus,
quadrivalent,
0.7mL
dose,
injectable,
preservative
free
|
198
http://hl7.org/fhir/sid/cvx
|
198
|
DTP-hepB-Hib
Pentavalent
Non-US
|
Diphtheria,
pertussis,
tetanus,
hepatitis
B,
Haemophilus
Influenza
Type
b,
(Pentavalent)
|
200
http://hl7.org/fhir/sid/cvx
|
200
|
influenza,
Southern
Hemisphere,
pediatric,
preservative
free
|
influenza,
seasonal,
Southern
Hemisphere,
quadrivalent,
pediatric
0.25mL
dose,
preservative
free
|
201
http://hl7.org/fhir/sid/cvx
|
201
|
influenza,
Influenza,
Southern
Hemisphere,
preservative
free
quadrivalent,
PF
|
influenza,
Influenza,
seasonal,
Southern
Hemisphere,
quadrivalent,
0.5mL
0.5
mL
dose,
no
preservative
free
|
202
http://hl7.org/fhir/sid/cvx
|
202
|
influenza,
Southern
Hemisphere,
quadrivalent,
with
preservative
|
influenza,
seasonal,
Southern
Hemisphere,
quadrivalent,
0.5mL
dose,
with
preservative
|
203
http://hl7.org/fhir/sid/cvx
|
203
|
meningococcal
conjugate
quadrivalent,
MenACWY-TT
(MCV4)
|
meningococcal
polysaccharide
(groups
A,
C,
Y,
W-135)
tetanus
toxoid
conjugate
vaccine
0.5mL
dose,
preservative
free
|
204
http://hl7.org/fhir/sid/cvx
|
204
|
Ebola
Zaire
vaccine,
live,
recombinant,
1mL
dose
|
Ebola
Zaire
vaccine,
live,
recombinant,
1mL
dose
|
205
http://hl7.org/fhir/sid/cvx
|
205
|
Influenza
vaccine,
Influenza,
adjuvanted,
quadrivalent,
adjuvanted
PF
|
influenza,
seasonal
vaccine,
quadrivalent,
Influenza,
adjuvanted,
0.5mL
dose,
inactivated,
quadrivalent,
injectable,
preservative
free
|
206
http://hl7.org/fhir/sid/cvx
|
206
|
Vaccinia,
smallpox
Mpox
vaccine
live,
PF,
SQ
or
ID
injection
|
Vaccinia,
smallpox
monkeypox
vaccine,
live
attenuated,
preservative
free,
subcutaneous
or
intradermal
injection
|
207
http://hl7.org/fhir/sid/cvx
|
207
|
COVID-19,
mRNA,
LNP-S,
PF,
100
mcg/0.5mL
dose
or
50
mcg/0.25mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
100
mcg/0.5mL
dose
or
50
mcg/0.25mL
dose
|
208
http://hl7.org/fhir/sid/cvx
|
208
|
COVID-19,
mRNA,
LNP-S,
PF,
30
mcg/0.3
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
30
mcg/0.3mL
dose
|
210
http://hl7.org/fhir/sid/cvx
|
210
|
COVID-19
vaccine,
vector-nr,
rS-ChAdOx1,
PF,
0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
vector
non-replicating,
recombinant
spike
protein-ChAdOx1,
preservative
free,
0.5
mL
|
211
http://hl7.org/fhir/sid/cvx
|
211
|
COVID-19,
subunit,
rS-nanoparticle+Matrix-M1
Adjuvant,
PF,
0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
subunit,
recombinant
spike
protein-nanoparticle+Matrix-M1
Adjuvant,
preservative
free,
0.5mL
dose
|
212
http://hl7.org/fhir/sid/cvx
|
212
|
COVID-19
vaccine,
vector-nr,
rS-Ad26,
PF,
0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
vector
non-replicating,
recombinant
spike
protein-Ad26,
preservative
free,
0.5
mL
|
213
http://hl7.org/fhir/sid/cvx
|
213
|
SARS-COV-2
(COVID-19)
vaccine,
UNSPECIFIED
|
SARS-COV-2
(COVID-19)
vaccine,
UNSPECIFIED
|
214
http://hl7.org/fhir/sid/cvx
|
214
|
Ebola,
unspecified
|
Ebola,
unspecified
|
215
http://hl7.org/fhir/sid/cvx
|
215
|
Pneumococcal
conjugate
PCV15,
polysaccharide
CRM197
conjugate,
adjuvant,
PF
|
Pneumococcal
conjugate
vaccine
15-valent
(PCV15),
polysaccharide
CRM197
conjugate,
adjuvant,
preservative
free
|
216
http://hl7.org/fhir/sid/cvx
|
216
|
Pneumococcal
conjugate
PCV20,
polysaccharide
CRM197
conjugate,
adjuvant,
PF
|
Pneumococcal
conjugate
vaccine
20-valent
(PCV20),
polysaccharide
CRM197
conjugate,
adjuvant,
preservative
free
|
217
http://hl7.org/fhir/sid/cvx
|
217
|
COVID-19,
mRNA,
LNP-S,
PF,
30
mcg/0.3
mL
dose,
tris-sucrose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
30
mcg/0.3mL
dose,
tris-sucrose
formulation
|
218
http://hl7.org/fhir/sid/cvx
|
218
|
COVID-19,
mRNA,
LNP-S,
PF,
10
mcg/0.2
mL
dose,
tris-sucrose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
10
mcg/0.2mL
dose,
tris-sucrose
formulation
|
219
http://hl7.org/fhir/sid/cvx
|
219
|
COVID-19,
mRNA,
LNP-S,
PF,
3
mcg/0.2
mL
dose,
tris-sucrose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
3
mcg/0.2mL
dose,
tris-sucrose
formulation
|
220
http://hl7.org/fhir/sid/cvx
|
220
|
HepB
recombinant,
3-antigen,
Al(OH)3
|
Hepatitis
B
vaccine
(recombinant),
3-antigen,
Al(OH)3
adjuvanted
|
221
http://hl7.org/fhir/sid/cvx
|
221
|
COVID-19,
mRNA,
LNP-S,
PF,
50
mcg/0.5
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
50
mcg/0.5
mL
dose
|
222
http://hl7.org/fhir/sid/cvx
|
222
|
Tick-borne
encephalitis,
unspecified
|
Tick-borne
encephalitis
vaccine,
unspecified
|
223
http://hl7.org/fhir/sid/cvx
|
223
|
Tick-borne
encephalitis,
inactivated,
PF,
0.25mL
|
Tick-borne
encephalitis
vaccine,
inactivated,
preservative
free,
0.25mL
dose
|
224
http://hl7.org/fhir/sid/cvx
|
224
|
Tick-borne
encephalitis,
inactivated,
PF,
0.5mL
|
Tick-borne
encephalitis
vaccine,
inactivated,
preservative
free,
0.5mL
dose
|
225
http://hl7.org/fhir/sid/cvx
|
225
|
COVID-19,
D614,
recomb,
preS
dTM,
AS03
adjuvant
add,
PF,
5mcg/0.5mL
|
SARS-COV-2
(COVID-19)
vaccine,
D614,
prefusion
spike
recombinant
protein
subunit
(CoV2
preS
dTM),
AS03
adjuvant
added,
preservative
free,
5mcg/0.5mL
dose
|
226
http://hl7.org/fhir/sid/cvx
|
226
|
COVID-19,
D614,
recomb,
preS
dTM,
AS03
adjuvant
add,
PF,
10mcg/0.5mL
|
SARS-COV-2
(COVID-19)
vaccine,
D614,
prefusion
spike
recombinant
protein
subunit
(CoV2
preS
dTM),
AS03
adjuvant
added,
preservative
free,
10mcg/0.5mL
dose
|
227
http://hl7.org/fhir/sid/cvx
|
227
|
COVID-19,
mRNA,
LNP-S,
PF,
pediatric
50
mcg/0.5
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
pediatric
50
mcg/0.5
mL
dose
|
228
http://hl7.org/fhir/sid/cvx
|
228
|
COVID-19,
mRNA,
LNP-S,
PF,
pediatric
25
mcg/0.25
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
pediatric
25
mcg/0.25
mL
dose
|
229
http://hl7.org/fhir/sid/cvx
|
229
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
50
mcg/0.5
mL
or
25mcg/0.25
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
50
mcg/0.5
mL
or
25
mcg/0.25
mL
dose
|
230
http://hl7.org/fhir/sid/cvx
|
230
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
10
mcg/0.2
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
10
mcg/0.2
mL
dose
|
231
http://hl7.org/fhir/sid/cvx
|
231
|
influenza,
Southern
Hemisphere,
high-dose,
quadrivalent
|
influenza,
seasonal,
Southern
Hemisphere,
high-dose,
quadrivalent,
0.7mL
dose,
preservative
free
|
300
http://hl7.org/fhir/sid/cvx
|
300
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
30
mcg/0.3
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
30
mcg/0.3
mL
dose,
tris-sucrose
formulation
|
301
http://hl7.org/fhir/sid/cvx
|
301
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
10
mcg/0.2
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
10
mcg/0.2
mL
dose,
tris-sucrose
formulation
|
302
http://hl7.org/fhir/sid/cvx
|
302
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
3
mcg/0.2
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
3
mcg/0.2
mL
dose,
tris-sucrose
formulation
|
303
http://hl7.org/fhir/sid/cvx
|
303
|
RSV,
recombinant,
protein
subunit
RSVpreF,
adjuvant
reconstituted,
0.5
mL,
PF
|
Respiratory
syncytial
virus
(RSV),
vaccine,
recombinant,
protein
subunit
RSV
prefusion
F,
adjuvant
reconstituted,
0.5
mL,
preservative
free
|
304
http://hl7.org/fhir/sid/cvx
|
304
|
Respiratory
syncytial
virus
(RSV),
unspecified
|
Respiratory
syncytial
virus
(RSV),
unspecified
|
305
http://hl7.org/fhir/sid/cvx
|
305
|
RSV,
bivalent,
protein
subunit
RSVpreF,
diluent
reconstituted,
0.5
mL,
PF
|
Respiratory
syncytial
virus
(RSV),
vaccine,
bivalent,
protein
subunit
RSV
prefusion
F,
diluent
reconstituted,
0.5
mL,
preservative
free
|
306
http://hl7.org/fhir/sid/cvx
|
306
|
RSV,
mAb,
nirsevimab-alip,
0.5
mL,
neonate
to
24
months
|
Respiratory
syncytial
virus
(RSV)
monoclonal
antibody,
IgG1κ
,
(nirsevimab-alip),
0.5
mL,
neonates
and
children
to
24
months
|
307
http://hl7.org/fhir/sid/cvx
|
307
|
RSV,
mAb,
nirsevimab-alip,
1
mL,
neonate
to
24
months
|
Respiratory
syncytial
virus
(RSV)
monoclonal
antibody,
IgG1κ
,
(nirsevimab-alip),
1
mL,
neonates
and
children
to
24
months
|
308
http://hl7.org/fhir/sid/cvx
|
308
|
COVID-19,
mRNA,
LNP-S,
PF,
tris-sucrose,
3
mcg/0.3
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
tris-sucrose,
3
mcg/0.3
mL
dose
|
309
http://hl7.org/fhir/sid/cvx
|
309
|
COVID-19,
mRNA,
LNP-S,
PF,
tris-sucrose,
30
mcg/0.3
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
tris-sucrose,
30
mcg/0.3
mL
dose
|
310
http://hl7.org/fhir/sid/cvx
|
310
|
COVID-19,
mRNA,
LNP-S,
PF,
tris-sucrose,
10
mcg/0.3
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
tris-sucrose,
10
mcg/0.3
mL
dose
|
311
http://hl7.org/fhir/sid/cvx
|
311
|
COVID-19,
mRNA,
LNP-S,
PF,
25
mcg/0.25
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
25
mcg/0.25
mL
dose
|
312
http://hl7.org/fhir/sid/cvx
|
312
|
COVID-19,
mRNA,
LNP-S,
PF,
50
mcg/0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
50
mcg/0.5
mL
dose
|
313
http://hl7.org/fhir/sid/cvx
|
313
|
COVID-19,
subunit,
rS-nanoparticle,
adjuvanted,
PF,
5
mcg/0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
subunit,
recombinant
spike
protein-nanoparticle+Matrix-M1
Adjuvant,
preservative
free,
5
mcg/0.5
mL
dose
|
314
http://hl7.org/fhir/sid/cvx
|
314
|
Respiratory
syncytial
virus
(RSV)
vaccine,
unspecified
|
Respiratory
syncytial
virus
(RSV)
vaccine,
unspecified
|
315
http://hl7.org/fhir/sid/cvx
|
315
|
Respiratory
syncytial
virus
(RSV)
MAB,
unspecified
|
Respiratory
syncytial
virus
(RSV)
monoclonal
antibody
(MAB),
unspecified
|
316
http://hl7.org/fhir/sid/cvx
|
316
|
meningococcal
Meningococcal
polysaccharide
(MenACWY-TT
conjugate),
(MenB),
PF
|
meningococcal
Meningococcal
polysaccharide
(groups
A,
C,
Y,
W)
tetanus
toxoid
conjugate,
meningococcal
B
recombinant
vaccine,
0.5mL,
preservative
free
|
317
http://hl7.org/fhir/sid/cvx
|
317
|
Chikungunya
live
attenuated
vaccine,
0.5
mL,
PF
|
Chikungunya,
live
attenuated
vaccine,
0.5
mL,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
318
|
Anthrax,
post-exposure
prophylaxis
|
Anthrax
vaccine,
adsorbed,
adjuvanted,
post-exposure
prophylaxis
|
http://hl7.org/fhir/sid/cvx
|
319
|
Anthrax
vaccine,
unspecified
|
Anthrax
vaccine,
unspecified
|
500
http://hl7.org/fhir/sid/cvx
|
320
|
Influenza,
MDCK,
trivalent,
preservative
|
Influenza,
Madin
Darby
Canine
Kidney,
subunit,
trivalent,
injectable,
contains
preservative
|
http://hl7.org/fhir/sid/cvx
|
321
|
Influenza-avian,
H5N8,
monovalent,
PF
|
Influenza-avian,
H5N8,
viral-vector,
monovalent,
injectable,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
322
|
Influenza-avian,
H5N8,
monovalent,
preservative
|
Influenza-avian,
H5N8,
viral-vector,
monovalent,
injectable,
contains
preservative
|
http://hl7.org/fhir/sid/cvx
|
323
|
Influenza-avian,
H5,
unspecified
formulation
|
Influenza-avian,
H5,
unspecified
formulation
|
http://hl7.org/fhir/sid/cvx
|
324
|
Poliovirus,
inactivated,
fractional-dose
(fIPV)
|
Poliovirus,
inactivated,
fractional-dose
(fIPV)
|
http://hl7.org/fhir/sid/cvx
|
325
|
Vaccinia
(smallpox,
mpox),
unspecified
|
Vaccinia
(smallpox,
mpox),
unspecified
|
http://hl7.org/fhir/sid/cvx
|
326
|
RSV,
mRNA,
injectable,
PF
|
Respiratory
syncytial
virus
(RSV),
mRNA,
injectable,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
327
|
Pneumococcal
conjugate
PCV21,
polysaccharide
CRM197
conjugate,
PF
|
Pneumococcal
conjugate
vaccine,
21
valent
(PCV21),
polysaccharide
CRM197
conjugate,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
328
|
Meningococcal
oligosaccharide
(MenACWY),
(MenB),
PF
|
Meningococcal
oligosaccharide
conjugated
(groups
A,
C,
W,
Y)
and
group
B,
0.5
mL,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
329
|
Chikungunya,
VLP,
recombinant,
0.8
mL,
PF
|
Chikungunya,
virus-like
particle
(VLP),
recombinant
vaccine,
0.8
mL,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
330
|
Dengue
fever,
unspecified
|
Dengue
fever,
unspecified
formulation
|
http://hl7.org/fhir/sid/cvx
|
331
|
Influenza,
Southern
Hemisphere,
trivalent,
PF
|
Influenza,
seasonal,
Southern
Hemisphere,
trivalent,
0.5
mL
dose,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
332
|
RSV,
mAb,
clesrovimab-cfor,
0.7
mL,
neonate
and
infant,
PF
|
Respiratory
syncytial
virus
(RSV),
monoclonal
antibody,
IgG1κ
,
(clesrovimab-cfor),
0.7
mL,
neonate
and
infant,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
333
|
Influenza,
live,
trivalent,
intranasal,
self/caregiver
admin,
PF
|
Influenza,
live,
trivalent,
intranasal,
self
or
caregiver
administered,
preservative
free
|
http://hl7.org/fhir/sid/cvx
|
500
|
COVID-19
Non-US
Vaccine,
Product
Unknown
|
SARS-COV-2
COVID-19
Non-US
Vaccine,
Specific
Product
Unknown
|
501
http://hl7.org/fhir/sid/cvx
|
501
|
COVID-19
IV
Non-US
Vaccine
(QAZCOVID-IN)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(QAZCOVID-IN)
|
502
http://hl7.org/fhir/sid/cvx
|
502
|
COVID-19
IV
Non-US
Vaccine
(COVAXIN)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(COVAXIN)
|
503
http://hl7.org/fhir/sid/cvx
|
503
|
COVID-19
LAV
Non-US
Vaccine
(COVIVAC)
|
SARS-COV-2
COVID-19
Live
Attenuated
Virus
Non-US
Vaccine
Product
(COVIVAC)
|
504
http://hl7.org/fhir/sid/cvx
|
504
|
COVID-19
VVnr
Non-US
Vaccine
(Sputnik
Light)
|
SARS-COV-2
COVID-19
Viral
Vector
Non-replicating
Non-US
Vaccine
Product
(Sputnik
Light)
|
505
http://hl7.org/fhir/sid/cvx
|
505
|
COVID-19
VVnr
Non-US
Vaccine
(Sputnik
V)
|
SARS-COV-2
COVID-19
Viral
Vector
Non-replicating
Non-US
Vaccine
Product
(Sputnik
V)
|
506
http://hl7.org/fhir/sid/cvx
|
506
|
COVID-19
VVnr
Non-US
Vaccine
(CanSino
Biological
Inc./Beijing
Institute
of
Biotechnology
|
SARS-COV-2
COVID-19
Viral
Vector
Non-replicating
Non-US
Vaccine
Product
(CONVIDECIA),
CanSino
Biological
Inc./Beijing
Institute
of
Biotechnology
|
507
http://hl7.org/fhir/sid/cvx
|
507
|
COVID-19
PS
Non-US
Vaccine
(Anhui
Zhifei
Longcom
Biopharm
+
Inst
of
Micro,
Chinese
Acad
of
Sciences)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Anhui
Zhifei
Longcom
Biopharmaceutical
+
Institute
of
Microbiology,
Chinese
Academy
of
Sciences)
|
508
http://hl7.org/fhir/sid/cvx
|
508
|
COVID-19
PS
Non-US
Vaccine
(Jiangsu
Province
Centers
for
Disease
Control
and
Prevention)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Jiangsu
Province
Centers
for
Disease
Control
and
Prevention)
|
509
http://hl7.org/fhir/sid/cvx
|
509
|
COVID-19
PS
Non-US
Vaccine
(EpiVacCorona)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(EpiVacCorona)
|
510
http://hl7.org/fhir/sid/cvx
|
510
|
COVID-19
IV
Non-US
Vaccine
(BIBP,
Sinopharm)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(BIBP,
Sinopharm)
|
511
http://hl7.org/fhir/sid/cvx
|
511
|
COVID-19
IV
Non-US
Vaccine
(CoronaVac,
Sinovac)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(CoronaVac,
Sinovac)
|
512
http://hl7.org/fhir/sid/cvx
|
512
|
SARS-COV-2
COVID-19
VLP
Non-US
Vaccine
(Medicago,
Covifenz)
|
SARS-COV-2
COVID-19
Virus
Like
Particle
(VLP)
Non-US
Vaccine
Product
(Medicago,
Covifenz)
|
513
http://hl7.org/fhir/sid/cvx
|
513
|
SARS-COV-2
COVID-19
PS
Non-US
Vaccine
(Anhui
Zhifei
Longcom,
Zifivax)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Anhui
Zhifei
Longcom,
Zifivax)
|
514
http://hl7.org/fhir/sid/cvx
|
514
|
SARS-COV-2
COVID-19
DNA
Non-US
Vaccine
(Zydus
Cadila,
ZyCoV-D)
|
SARS-COV-2
COVID-19
DNA
Non-US
Vaccine
Product
(Zydus
Cadila,
ZyCoV-D)
|
515
http://hl7.org/fhir/sid/cvx
|
515
|
SARS-COV-2
COVID-19
PS
Non-US
Vaccine
(Medigen,
MVC-COV1901)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Medigen,
MVC-COV1901)
|
516
http://hl7.org/fhir/sid/cvx
|
516
|
COV-2
COVID-19
Inactivated
Non-US
Vaccine
Product
(Minhai
Biotechnology
Co,
KCONVAC)
|
SARS-COV-2
COVID-19
Inactivated
Non-US
Vaccine
Product
(Minhai
Biotechnology
Co,
KCONVAC)
|
517
http://hl7.org/fhir/sid/cvx
|
517
|
SARS-COV-2
COVID-19
PS
Non-US
Vaccine
(Biological
E
Limited,
Corbevax)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Biological
E
Limited,
Corbevax)
|
518
http://hl7.org/fhir/sid/cvx
|
518
|
COVID-19
Inactivated,
Non-US
Vaccine
(VLA2001,
Valneva)
|
SARS-COV-2
COVID-19
Inactivated,
Non-US
Vaccine
(VLA2001,
Valneva)
|
519
http://hl7.org/fhir/sid/cvx
|
519
|
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
(Spikevax
Bivalent),
Moderna
|
SARS-COV-2
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
(Spikevax
Bivalent),
Moderna
|
520
http://hl7.org/fhir/sid/cvx
|
520
|
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
Product,
Pfizer-BioNTech
|
SARS-COV-2
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
Product
(Comirnaty
Bivalent),
Pfizer-BioNTech
|
521
http://hl7.org/fhir/sid/cvx
|
521
|
COVID-19
SP,
protein-based,
adjuvanted
(VidPrevtyn
Beta),
Sanofi-GSK
|
SARS-COV-2
(COVID-19)
vaccine
SP,
protein-based,
adjuvanted,
B.1.351
strain
(VidPrevtyn
Beta),
Sanofi-GSK
|
801
http://hl7.org/fhir/sid/cvx
|
801
|
AS03
Adjuvant
|
AS03
Adjuvant
|
998
http://hl7.org/fhir/sid/cvx
|
998
|
no
vaccine
administered
|
no
vaccine
administered
|
999
http://hl7.org/fhir/sid/cvx
|
999
|
unknown
|
unknown
vaccine
or
immune
globulin
|
AGRPAL
urn:oid:1.2.36.1.2001.1005.17
|
AGRPAL
|
Agrippal
|
|
AVAXM
urn:oid:1.2.36.1.2001.1005.17
|
AVAXM
|
Avaxim
|
|
BCG
urn:oid:1.2.36.1.2001.1005.17
|
BCG
|
BCG
|
|
CDT
urn:oid:1.2.36.1.2001.1005.17
|
CDT
|
CDT
|
|
CMX
urn:oid:1.2.36.1.2001.1005.17
|
CMX
|
COMVAX
|
|
DTP
urn:oid:1.2.36.1.2001.1005.17
|
DTP
|
Triple
Antigen
|
|
DTPA
urn:oid:1.2.36.1.2001.1005.17
|
DTPA
|
DTPa
|
|
ENGP
urn:oid:1.2.36.1.2001.1005.17
|
ENGP
|
Engerix
B
|
|
FLRIX
urn:oid:1.2.36.1.2001.1005.17
|
FLRIX
|
Fluarix
|
|
FLUVAX
urn:oid:1.2.36.1.2001.1005.17
|
FLUVAX
|
Fluvax
|
|
FLVRN
urn:oid:1.2.36.1.2001.1005.17
|
FLVRN
|
Fluvirin
|
|
FVXJNR
urn:oid:1.2.36.1.2001.1005.17
|
FVXJNR
|
Fluvax
Junior
|
|
GNDIP
urn:oid:1.2.36.1.2001.1005.17
|
GNDIP
|
Diphtheria
|
|
GNFLU
urn:oid:1.2.36.1.2001.1005.17
|
GNFLU
|
Influenza
|
|
GNHEP
urn:oid:1.2.36.1.2001.1005.17
|
GNHEP
|
Hepatitis
B
|
|
GNHIB
urn:oid:1.2.36.1.2001.1005.17
|
GNHIB
|
HIB
|
|
GNHPA
urn:oid:1.2.36.1.2001.1005.17
|
GNHPA
|
Hepatitis
A
|
|
GNJEN
urn:oid:1.2.36.1.2001.1005.17
|
GNJEN
|
Japanese
Encephalitis
|
|
GNMEA
urn:oid:1.2.36.1.2001.1005.17
|
GNMEA
|
Measles
|
|
GNMEN
urn:oid:1.2.36.1.2001.1005.17
|
GNMEN
|
Meningococcal
C
|
|
GNMUM
urn:oid:1.2.36.1.2001.1005.17
|
GNMUM
|
Mumps
|
|
GNPNE
urn:oid:1.2.36.1.2001.1005.17
|
GNPNE
|
Pneumococcal
|
|
GNPOL
urn:oid:1.2.36.1.2001.1005.17
|
GNPOL
|
Polio
|
|
GNROX
urn:oid:1.2.36.1.2001.1005.17
|
GNROX
|
Rotavirus
|
|
GNRUB
urn:oid:1.2.36.1.2001.1005.17
|
GNRUB
|
Rubella
|
|
GNTET
urn:oid:1.2.36.1.2001.1005.17
|
GNTET
|
Tetanus
|
|
GNVAR
urn:oid:1.2.36.1.2001.1005.17
|
GNVAR
|
Varicella
|
|
HATWNJ
urn:oid:1.2.36.1.2001.1005.17
|
HATWNJ
|
Twinrix
Junior
|
|
HAVAQ
urn:oid:1.2.36.1.2001.1005.17
|
HAVAQ
|
Vaqta
Paed/Adol
|
|
HAVJ
urn:oid:1.2.36.1.2001.1005.17
|
HAVJ
|
Havrix
Junior
|
|
HBOC
urn:oid:1.2.36.1.2001.1005.17
|
HBOC
|
HibTITER
|
|
HBV
urn:oid:1.2.36.1.2001.1005.17
|
HBV
|
HBV
|
|
HBVP
urn:oid:1.2.36.1.2001.1005.17
|
HBVP
|
HBVAX
II
|
|
HBX
urn:oid:1.2.36.1.2001.1005.17
|
HBX
|
Hiberix
|
|
IFHX
urn:oid:1.2.36.1.2001.1005.17
|
IFHX
|
Infanrix
Hexa
|
|
IFIP
urn:oid:1.2.36.1.2001.1005.17
|
IFIP
|
Infanrix-IPV
|
|
IFPA
urn:oid:1.2.36.1.2001.1005.17
|
IFPA
|
Infanrix
Penta
|
|
IFX
urn:oid:1.2.36.1.2001.1005.17
|
IFX
|
Infanrix
|
|
IFXB
urn:oid:1.2.36.1.2001.1005.17
|
IFXB
|
InfanrixHepB
|
|
INFLUV
urn:oid:1.2.36.1.2001.1005.17
|
INFLUV
|
Influvac
|
|
IPV
urn:oid:1.2.36.1.2001.1005.17
|
IPV
|
IPOL
|
|
JEVAX
urn:oid:1.2.36.1.2001.1005.17
|
JEVAX
|
JE-VAX
|
|
MENJUG
urn:oid:1.2.36.1.2001.1005.17
|
MENJUG
|
Menjugate
|
|
MENTEC
urn:oid:1.2.36.1.2001.1005.17
|
MENTEC
|
Meningitec
|
|
MENUME
urn:oid:1.2.36.1.2001.1005.17
|
MENUME
|
Menomune
|
|
MENVAX
urn:oid:1.2.36.1.2001.1005.17
|
MENVAX
|
Mencevax
ACWY
|
|
MMR
urn:oid:1.2.36.1.2001.1005.17
|
MMR
|
MMR
|
|
MMRCSL
urn:oid:1.2.36.1.2001.1005.17
|
MMRCSL
|
MMR
II
|
|
MMRSKB
urn:oid:1.2.36.1.2001.1005.17
|
MMRSKB
|
Priorix
|
|
MNTRX
urn:oid:1.2.36.1.2001.1005.17
|
MNTRX
|
Menitorix
|
|
NEISVC
urn:oid:1.2.36.1.2001.1005.17
|
NEISVC
|
NeisVac-C
|
|
OPV
urn:oid:1.2.36.1.2001.1005.17
|
OPV
|
Polio
|
|
P
urn:oid:1.2.36.1.2001.1005.17
|
P
|
Pertussis
|
|
PANVAX
urn:oid:1.2.36.1.2001.1005.17
|
PANVAX
|
Panvax
|
|
PDCL
urn:oid:1.2.36.1.2001.1005.17
|
PDCL
|
Pediacel
|
|
PLCL
urn:oid:1.2.36.1.2001.1005.17
|
PLCL
|
Poliacel
|
|
PNEUMO
urn:oid:1.2.36.1.2001.1005.17
|
PNEUMO
|
Pneumovax
|
|
PRPD
urn:oid:1.2.36.1.2001.1005.17
|
PRPD
|
ProHIBit
|
|
PROQAD
urn:oid:1.2.36.1.2001.1005.17
|
PROQAD
|
ProQuad
|
|
PRPOMP
urn:oid:1.2.36.1.2001.1005.17
|
PRPOMP
|
PedvaxHIB
|
|
PRPT
urn:oid:1.2.36.1.2001.1005.17
|
PRPT
|
ActHIB
|
|
PRVNR
urn:oid:1.2.36.1.2001.1005.17
|
PRVNR
|
Prevenar
7
|
|
PRVTH
urn:oid:1.2.36.1.2001.1005.17
|
PRVTH
|
Prevenar
13
|
|
PRXTEX
urn:oid:1.2.36.1.2001.1005.17
|
PRXTEX
|
Priorix-Tetra
|
|
QDCL
urn:oid:1.2.36.1.2001.1005.17
|
QDCL
|
Quadracel
|
|
ROTRIX
urn:oid:1.2.36.1.2001.1005.17
|
ROTRIX
|
Rotarix
|
|
ROTTEQ
urn:oid:1.2.36.1.2001.1005.17
|
ROTTEQ
|
Rotateq
|
|
SYNFLX
urn:oid:1.2.36.1.2001.1005.17
|
SYNFLX
|
Synflorix
|
|
TCL
urn:oid:1.2.36.1.2001.1005.17
|
TCL
|
Tripacel
|
|
VAXGRP
urn:oid:1.2.36.1.2001.1005.17
|
VAXGRP
|
Vaxigrip
|
|
VGRJNR
urn:oid:1.2.36.1.2001.1005.17
|
VGRJNR
|
Vaxigrip
Junior
|
|
VLRIX
urn:oid:1.2.36.1.2001.1005.17
|
VLRIX
|
Varilrix
|
|
VRVAX
urn:oid:1.2.36.1.2001.1005.17
|
VRVAX
|
Varivax
|
|